Abstract
The high proliferation rate of cancer cells, together with environmental factors such as hypoxia and nutrient deprivation can cause Endoplasmic Reticulum (ER) stress. The protein kinase PERK is an essential mediator in one of the three ER stress response pathways. Genetic and pharmacological inhibition of PERK has been reported to limit tumor growth in xenograft models. Here we provide evidence that inactive PERK interacts with the nuclear pore-associated Vault complex protein and that this compromises Vault-mediated nuclear transport of PTEN. Pharmacological inhibition of PERK under ER stress results is abnormal sequestration of the Vault complex, leading to increased cytoplasmic PTEN activity and lower AKT activation. As the PI3K/PTEN/AKT pathway is crucial for many aspects of cell growth and survival, this unexpected effect of PERK inhibitors on AKT activity may have implications for their potential use as therapeutic agents.
Original language | English |
---|---|
Journal | Cellular Signalling |
Volume | 27 |
Issue number | 3 |
Pages (from-to) | 436-42 |
Number of pages | 7 |
ISSN | 0898-6568 |
DOIs | |
Publication status | Published - 1 Mar 2015 |
Keywords
- Amino Acid Substitution
- Cell Line, Tumor
- Endoplasmic Reticulum Stress
- Forkhead Transcription Factors
- HEK293 Cells
- HeLa Cells
- Hep G2 Cells
- Humans
- Nuclear Proteins
- PTEN Phosphohydrolase
- Phosphatidylinositol 3-Kinases
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins c-akt
- Signal Transduction
- Vault Ribonucleoprotein Particles
- eIF-2 Kinase